XXXiaofeng Xie

Xiaofeng Xie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaofeng Xie has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Longfei Li

    Hebei University

    4 shared publications
  • Xueqing Song

    Hebei University

    4 shared publications
  • Henry F. Schaefer

    University of Georgia

    2 shared publications
  • Jiejing Zhang

    College of Pharmacy, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Hebei University, Baoding 071002, Hebei, P. R. China

    2 shared publications
  • Chengyan Zhou

    College of Pharmaceutical Science, Hebei University, Baoding 071002, China; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Hebei University, Baoding 071002, China

    1 shared publication
  • Fei Cao

    College of Pharmaceutical Sciences, Key Laboratory of Medicinal Chemistry and Molecular Diagnostics of Education Ministry of China, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding 071002, China

    1 shared publication

Latest Publications

  • Open Access

    Unveiling Unusual Reactivity of SO2 and Unusual Type of S–X Long Bonds

    by Shuai Ma, Longfei Li, Xiaofeng Xie, Peng Wang, He Bai, Kan Yang, Xueqing Song, Henry F. Schaefer

    A new reactivity of SO2 to form unusual stable M-X-SO2 (X = F, Cl, H) complexes is unveiled in this study. Moreover, a new type of S-X long bonds, which are significantly longer than traditional S-X covalent bonds, has been discovered. The P,N-ligated Ni-F complex model 1A can bind a SO2 molecule through the new F-S long bond (2.207 Å), and a stable Ni-F-SO2 complex 1B is generated, being exergonic by 2.2 kcal/mol. According to natural localized molecular orbital analysis, the new S-F long bond has a unique p(F) → π*(O═S═O) bonding interaction, which is shown to arise from the long S-F length. In comparison, the strength of the new F-S long bond (-2.2 kcal/mol) is found to be significantly stronger than common noncovalent interactions such as the hydrogen and halogen bond. The substituent modulations suggest that the electron-donating groups can increase the strength of new F-S bonds and enhance binding free energies ΔGbind. The scope of possible M-X complexes was explored, and various metals and X (F, Cl, and H) ligands were found to form stable M-X-SO2 complexes. Specifically, the anionic M-X complexes display much higher ΔGbind values, ranging from -8 to -10 kcal/mol. The study paves the way for a green, recyclable, and adjustable SO2 absorption method.


  • Open Access

    Biomimetic Frustrated Lewis Pair Catalysts for Hydrogenation of CO to Methanol at Low Temperatures

    by Jiejing Zhang, Longfei Li, Xiaofeng Xie, Xue-Qing Song, Henry F. Schaefer

    The industrial production of methanol through CO hydrogenation using the Cu/ZnO/Al2O3 catalyst requires harsh conditions, and the development of new catalysts with low operating temperatures is highly desirable. In this study, organic biomimetic FLP catalysts with good tolerance to CO poison are theoretically designed. The base-free catalytic reaction contains the 1,1-addition of CO into a formic acid intermediate and the hydrogenation of the formic acid intermediate into methanol. Low-energy spans (25.6, 22.1, and 20.6 kcal/mol) are achieved, indicating that CO can be hydrogenated into methanol at low temperatures. The new extended aromatization-dearomatization effect involving multiple rings is proposed to effectively facilitate the rate-determining CO 1,1-addition step, and a new CO activation model is proposed for organic catalysts.


  • Unveiling Pre-Transmetalation Intermediates in Base-Free Suzuki–Miyaura Cross-Couplings: A Computational Study

    by Xiaofeng Xie, Jiejing Zhang, Xue-Qing Song, Wan Li, Fei Cao, Chengyan Zhou, Huajie Zhu, Longfei Li

    The pre-transmetalation intermediates are critically important in Suzuki-Miyaura cross-coupling (SMC) reactions and have become a hot spot of the current research. However, the pre-transmetalation intermediates under base-free conditions have not been clear. Herein, a comprehensive theoretical study is performed on the base-free Pd-catalyzed desulfonative SMC reaction. The fragile coordination feature and the acceleration role of the RuPhos chelate ligand are revealed. The hydrogen-bond complex between the Pd-F complex and aryl boronic acid is identified as an important pre-transmetalation intermediate, which increases the energy span to 32.5 kcal/mol. The controlling factor for the formation of the hydrogen-bond complexes is attributed to the electronegativities of halogen atoms in the metal halide complexes. What is more, other reported SMC reaction systems involving metal halide complexes and aryl boronic acids are reconsidered and suggest that the hydrogen-bond complexes widely exist as stable pre-transmetalation intermediates with influencing the catalytic activities. The earth-abundant Ni-catalyzed desulfonative SMC reaction is further designed and predicted to have a higher activity than the original Pd-catalyzed SMC reaction.


  • Seratrodast platinum( iv ) hybrids efficiently inhibit cancer-related thrombosis and metastasis phenotype in vitro and in vivo

    by Xue-Qing Song, Yi-Xin Ding, Yu-Hang Zhang, Qing Xu, Xiaofeng Xie, Yali Song, Longfei Li

    Venous thromboembolism caused by Pt(II)-based chemotherapy regimens increases the risk of colon cancer metastasis, recurrence, and treatment failure. Therefore, the reduction of tumor thrombosis during chemotherapy has received much attention. Herein, a series of Pt(IV) hybrids based on the TXA2R antagonist seratrodast (SRT) were synthesized and named Seratplatin. Bioactivity studies found that compounds 3 and 4 had stronger cytotoxicity and selectivity against cancer cells among four SRT-derived Pt(IV) complexes, especially compound 3, which demonstrated a nanomolar IC50 value and 42-fold lower than that in CDDP. Studies on the mechanism indicated that the cisplatin-like prodrugs are accumulated more in cells, but only compound 3 with rapid reducing properties could induce severe DNA damage, ROS production, S-phase arrest, and cell apoptosis. Most strikingly, 3 had a higher binding affinity than SRT alone or the other three derivatives and effectively inhibited the expression of TXA2R at a dose of only 0.1 times that of free SRT, thereby preventing platelet aggregation and tumor thrombosis. Compound 3 exerted anti-metastasis, anti-invasion, and anti-angiogenesis via the down-regulation of vimentin, VEGFA, MMP-9, and up-regulation of E-cadherin. In in vivo tests, compound 3 displayed a high anti-tumor effect without significant weight changes or tissue damage in HCT-116 tumor-bearing mice. Overall, these findings shed light on the special therapeutic effects of SRT-derived Pt(IV) prodrugs for cancer therapy.


  • Open Access

    Research on the Prevention and Control of COVID-19 Risk in Long-term Care Facilities based on Prospect Theory

    by Fengying Zhang, Jianhui Kong, Xiaofeng Xie, Kai Xu, Zongfang Zhou

    In the current complex and uncertainty of the risk of COVID-19 in long-term care facilities, the elderly in the long-term care facilities are at the highest risk of being affected by COVID-19. There is still uncertain relationship between the identification of this risk and the care management, caring behavior, cannot achieve management optimization. Matrix analysis the change relation between the conditions for the COVID-19 risk identification and risk behavior. The results show that there are N equilibrium points for the risk management of COVID-19 in long-term care facilities. The complexity of the risk of COVID-19 in long-term care facilities and the cognitive deviations caused by the limited rationality of managers and caregivers make the COVID-19, the risk early warning system is not easy to converge to a stable point in the real environment, so as to achieve the best management status of the COVID-19 risk in long-term care facilities. Nursing staff behavior, risk management cost, risk loss and other parameters have different risk management effects for the COVID-19. When the selected parameter is adjusted through the threshold, reflects the stability and selection tendency of the COVID-19 risk management strategy. Promote institutional managers and caregivers to adopt active risk management strategies: Strengthen the awareness of institutional managers and caregivers about the complexity and uncertainty of risks; Optimize the COVID-19 risk management system, process and procedures; Strengthen the research on risk accidents, serious consequences and effective prevention of COVID-19; Strengthen the review and supervision of the risk management of COVID-19 and improve its value perception of the effective prevention of the risk of COVID-19.